Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HC Surgical SpecialistsSGX:1B1 +1.45%63 EV-to-FCF is 6.71 as of Aug. 25, 2026, which is 24% below its 10-year median of 8.86. GuruFocus rates SGX:1B1 with a GF Score™ of 63/100 and a GF Value™ of S$0.30 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 104 Medical Diagnostics & Research companies, HC Surgical Specialists ranks better than 88.46% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, HC Surgical Specialists's Enterprise Value is S$47.97 Mil.
HC Surgical Specialists's Free Cash Flow for the trailing twelve months (TTM) ended in May. 2026 was S$7.15 Mil. Therefore, HC Surgical Specialists's EV-to-FCF for today is 6.71.
The historical rank and industry rank for HC Surgical Specialists's EV-to-FCF or its related term are showing as below:
SGX:1B1'
s EV-to-FCF Range Over the Past 10 Years
Min: 5.21 Med: 8.86 Max: 474.39
Current: 6.6
During the past 13 years, the highest EV-to-FCF of HC Surgical Specialists was 474.39. The lowest was 5.21. And the median was 8.86.
SGX:1B1's EV-to-FCF is ranked better than 88.46% of 104
companies
in the Medical Diagnostics & Research industry
Industry Median: 26.58
vs SGX:1B1: 6.60
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
HC Surgical Specialists (SGX:1B1) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
HC Surgical Specialists's PE Ratio (TTM) for today is calculated as:
HC Surgical Specialists's share price for today is S$0.35.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. HC Surgical Specialists's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2026 was S$0.046.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, HC Surgical Specialists's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HC Surgical Specialists EV-to-FCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, HC Surgical Specialists's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where HC Surgical Specialists's EV-to-FCF falls into.
HC Surgical Specialists's current Enterprise Value is S$47.97 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. HC Surgical Specialists's Free Cash Flow for the trailing twelve months (TTM) ended in May. 2026 was S$7.15 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HC Surgical Specialists (SGX:1B1) has a EV-to-FCF of 6.71 as of Aug. 25, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on HC Surgical Specialists and its competitors. This is 24% below median its historical median of 8.86. Over the past decade, HC Surgical Specialists' EV-to-FCF has ranged from 5.21 to 474.39. According to the industry distribution chart, HC Surgical Specialists ranks #12 out of 104 companies in the Medical Diagnostics & Research industry, placing it in the top 11.5%.
Is HC Surgical Specialists' EV-to-FCF too high?
HC Surgical Specialists' current EV-to-FCF of 6.71 is 24% below median its 10-year median of 8.86. Over the past 10 years, this metric has ranged from a low of 5.21 to a high of 474.39. The Medical Diagnostics & Research industry median EV-to-FCF is 26.58. HC Surgical Specialists' value of 6.71 is 74.8% below this industry median. Based on the distribution chart, HC Surgical Specialists ranks #12 out of 104 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, HC Surgical Specialists has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HC Surgical Specialists' EV-to-FCF compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, HC Surgical Specialists ranks #12 out of 104 companies for EV-to-FCF. This places HC Surgical Specialists in the top 12% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 26.58. HC Surgical Specialists' value of 6.71 is 74.8% below this benchmark. Historically, HC Surgical Specialists' own EV-to-FCF has ranged from 5.21 to 474.39 over the past decade. While the company's 10-year median is 8.86 vs. the industry median of 26.58, HC Surgical Specialists has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Diagnostics & Research company?
The median EV-to-FCF among Medical Diagnostics & Research companies is 26.58, based on 104 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HC Surgical Specialists's current EV-to-FCF of 6.71 is 74.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on HC Surgical Specialists and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-FCF is 26.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HC Surgical Specialists's current EV-to-FCF is 6.71, which is 24% below median its own 10-year median of 8.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HC Surgical Specialists stock overvalued right now?
Based on GuruFocus' analysis, HC Surgical Specialists (SGX:1B1) is currently considered Modestly Overvalued. The stock's GF Value™ is S$0.30, compared to a current price of S$0.35 — trading 16.7% above its estimated fair value. The current EV-to-FCF is 6.71, which is 24% below median its 10-year median of 8.86 and 74.8% below the Medical Diagnostics & Research industry median of 26.58. HC Surgical Specialists' overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For HC Surgical Specialists (SGX:1B1), the current EV-to-FCF is 6.71 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HC Surgical Specialists (SGX:1B1) Overvalued in 2026?
Based on GuruFocus' analysis, HC Surgical Specialists stock appears to be overvalued.
The current stock price of S$0.35 is trading 16.7% above its estimated GF Value™ of S$0.30.
GuruFocus considers HC Surgical Specialists to be Modestly Overvalued.
Key valuation signals for SGX:1B1:
EV-to-FCF: 6.71 (24% below median its 10-year median of 8.86)
GF Value™: S$0.30 vs. price of S$0.35 (16.7% above fair value)
Industry Position: 74.8% below the Medical Diagnostics & Research median (#12 of 104)
No single metric tells the full story. See the SGX:1B1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HC Surgical Specialists Ltd is a medical services group. The company is engaged in providing endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services. The operating segment of the company is the healthcare segment. Geographically, it operates only in Singapore. The company has its facilities center and clinics at various places in Singapore.
63GF Score
Get the complete analysis for SGX:1B1
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:1B1 has been successfully added to your 
